Understanding Chronic Kidney Disease Stage 4 (CKD Stage IV) is crucial for accurate clinical documentation and medical coding. This resource provides information on CKD Stage 4, including diagnosis criteria, treatment options, and managing Chronic Renal Failure Stage 4. Learn about GFR ranges, symptoms, and complications associated with Chronic Kidney Disease Roman Numeral 4 for improved healthcare outcomes. This guide also addresses Chronic Kidney Disease stage 4 ICD-10 codes and other relevant medical coding terminology.
Also known as
Chronic kidney disease, stage 4
Severe decrease in kidney function.
Hypertensive chronic kidney disease with stage 1 through stage 4 chronic kidney disease
Kidney disease caused by high blood pressure.
Hypertensive heart and chronic kidney disease, unspecified
Heart and kidney disease due to high blood pressure.
Diabetes mellitus
A group of metabolic disorders characterized by high blood sugar.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the documented diagnosis Chronic Kidney Disease Stage 4?
When to use each related code
| Description |
|---|
| Severe kidney damage with reduced GFR (15-29 mL/min) |
| Moderately reduced kidney function (GFR 30-59 mL/min) |
| Mildly reduced kidney function (GFR 60-89 mL/min) |
Insufficient documentation to support stage 4 specifically. Coding requires lab results and clinical findings.
Missing codes for associated hypertension, diabetes, or other contributing conditions impacting DRG assignment.
Unspecified laterality for kidney involvement if applicable. Documentation must clarify unilateral/bilateral disease.
Q: What are the key differentiating factors in chronic kidney disease stage 4 management compared to earlier stages, and how can clinicians optimize patient outcomes in this advanced stage?
A: Chronic kidney disease stage 4 management requires a more intensive approach compared to earlier stages due to the significant decline in kidney function (estimated glomerular filtration rate [eGFR] between 15-29 mL/min/1.73 m2). Key differentiating factors include closer monitoring of electrolyte imbalances (especially potassium and phosphorus), more aggressive management of hypertension and anemia, and detailed patient education regarding renal replacement therapy options (dialysis or transplantation). Optimizing patient outcomes in this advanced stage necessitates a multidisciplinary approach involving nephrologists, dietitians, social workers, and other healthcare professionals. Consider implementing a comprehensive care plan addressing medication management, dietary restrictions (protein, phosphorus, potassium), anemia management with erythropoiesis-stimulating agents (ESAs), and proactive planning for dialysis access or transplantation. Explore how early integration of palliative care can improve quality of life for patients with stage 4 CKD.
Q: How do I effectively communicate the prognosis and treatment options for chronic kidney disease stage 4 with patients and their families, addressing their emotional and psychological needs?
A: Communicating the prognosis and treatment options for chronic kidney disease stage 4 requires empathy, clarity, and a patient-centered approach. Start by assessing the patient's and family's understanding of CKD and their emotional preparedness for this information. Clearly explain the progressive nature of the disease and the implications of stage 4, including the eventual need for renal replacement therapy. Openly discuss the various treatment options, including hemodialysis, peritoneal dialysis, and kidney transplantation, highlighting the benefits and drawbacks of each. Acknowledge the emotional and psychological impact of this diagnosis, offering resources such as support groups, mental health professionals, and palliative care services. Learn more about effective communication strategies for delivering difficult news and supporting patients through advanced chronic illness. Encourage patients to actively participate in shared decision-making regarding their care.
Patient presents with chronic kidney disease stage 4 (CKD stage IV, chronic renal failure stage 4), confirmed by estimated glomerular filtration rate (eGFR) between 15 and 29 mL/min/1.73 m2 and persistent albuminuria. Relevant lab values include elevated serum creatinine and blood urea nitrogen (BUN). Patient reports symptoms consistent with CKD stage 4, including fatigue, swelling in the legs and feet, decreased urine output, loss of appetite, nausea, and difficulty sleeping. Medical history includes hypertension, managed with [medication name(s) and dosage(s)], and [mention any other relevant comorbidities, e.g., diabetes, cardiovascular disease]. Assessment indicates progression from previous stage 3 chronic kidney disease. The patient's current medication regimen was reviewed and adjusted as needed to optimize blood pressure control and mitigate CKD progression. Patient education provided on dietary restrictions, including protein restriction and potassium management, fluid intake guidelines, and the importance of medication adherence. Referral initiated to a nephrologist for further evaluation and management of CKD stage 4, including discussion of renal replacement therapy options such as dialysis or kidney transplant. Follow-up appointment scheduled in [timeframe] to monitor kidney function, electrolyte balance, and overall clinical status. ICD-10 code N18.4 assigned.